Jared Griffin Williamson, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 13205 Booker T Washington Hwy, Hardy, VA 24101 Phone: 540-719-1815 |
Mr. Marc Kalin, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 13205 Booker T Washington Hwy, Hardy, VA 24101 Phone: 540-719-1815 |
Mrs. Kathryn Renee Mueller, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 282 Westlake Rd, Hardy, VA 24101 Phone: 540-721-2689 Fax: 540-721-3623 |
Mr. Leonard B Galvan, PA C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 13205 Booker T Washington Hwy, Hardy, VA 24101 Phone: 540-719-1815 Fax: 540-719-2867 |
News Archive
In 1947-1949 a group of mental patients in Sweden were used as subjects in a full-scale experiment designed to bring about tooth decay. They were fed copious amounts of candy, and many of them had their teeth completely ruined. But, scientifically speaking, the experiment was a huge success.
Boehringer Ingelheim and Eli Lilly and Company will present the latest data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal, September 12-16.
A new therapy that reduces the risk of mortality and heart failure in patients with mild cardiac disease received a thumb's up this week from an advisory panel to the U.S. Food and Drug Administration. The panel recommended that the cardiac resynchronization therapy defibrillator (CRT-D), tested extensively nationwide under the leadership of cardiologist Arthur Moss, M.D., professor of Medicine at the University of Rochester Medical Center, be approved for use in patients with mild heart failure in the United States.
Imagine pain in an arm or leg so intense that the sufferer would rather undergo an amputation than put up with it any longer. For those with complex regional pain syndrome (CRPS), this is not just a hypothetical nightmare—it is reality.
NRTIs are compounds which were originally developed in the 1960s as anti-cancer agents. They are similar in structure to the bases which make up DNA, and it was hoped that they would interfere with DNA replication in fast-growing cancer cells, slowing down or stopping tumour growth.
› Verified 5 days ago